Copyright
©The Author(s) 2018.
World J Gastroenterol. Feb 14, 2018; 24(6): 725-736
Published online Feb 14, 2018. doi: 10.3748/wjg.v24.i6.725
Published online Feb 14, 2018. doi: 10.3748/wjg.v24.i6.725
Figure 1 Cumulative incidence of virological response.
A: Cumulative incidence of virological response in HBeAg-positive patients; B: Cumulative incidence of virological response in HBeAg-positive non-cirrhotic patients; C: Cumulative incidence of virological response in HBeAg-negative patients; D: Cumulative incidence of virological response in HBeAg-negative non-cirrhotic patients.
- Citation: Lin TC, Chiu YC, Chiu HC, Liu WC, Cheng PN, Chen CY, Chang TT, Wu IC. Clinical utility of hepatitis B surface antigen kinetics in treatment-naïve chronic hepatitis B patients during long-term entecavir therapy. World J Gastroenterol 2018; 24(6): 725-736
- URL: https://www.wjgnet.com/1007-9327/full/v24/i6/725.htm
- DOI: https://dx.doi.org/10.3748/wjg.v24.i6.725